CymitQuimica logo

CAS 3110124-60-9

:

Formel:C59H90N12O19
InChl:InChI=1S/C59H90N12O19/c60-20-22-61-23-24-62-48(72)17-15-46(57(86)87)70-29-25-68(36-51(76)77)27-31-71(32-28-69(26-30-70)37-52(78)79)47(58(88)89)16-18-49(73)64-35-38-8-12-41(13-9-38)53(80)65-45(34-39-10-11-40-5-1-2-6-42(40)33-39)54(81)63-21-4-3-7-43(55(82)83)66-59(90)67-44(56(84)85)14-19-50(74)75/h1-2,5-6,10-11,33,38,41,43-47,61H,3-4,7-9,12-32,34-37,60H2,(H,62,72)(H,63,81)(H,64,73)(H,65,80)(H,74,75)(H,76,77)(H,78,79)(H,82,83)(H,84,85)(H,86,87)(H,88,89)(H2,66,67,90)/t38?,41?,43-,44-,45-,46?,47?/m0/s1
InChI Key:BDTGBTUYXGCHTF-VKOWTPDASA-N
SMILES:C1CC(CCC1CNC(=O)CCC(C(=O)O)N2CCN(CCN(CCN(CC2)CC(=O)O)C(CCC(=O)NCCNCCN)C(=O)O)CC(=O)O)C(=O)N[C@@H](CC3=CC4=CC=CC=C4C=C3)C(=O)NCCCC[C@@H](C(=O)O)NC(=O)N[C@@H](CCC(=O)O)C(=O)O
1 Produkte gefunden.
  • Logo von CymitQuimica
    Targetmol
    + Info

    PDI2

    CAS:
    PDI2 (PSMA-DOTA-PEI2) is a ligand for prostate-specific membrane antigen (PSMA) that functions as a tumor retention agent, a reducer of renal uptake, an imaging agent, and an antitumor agent for SPECT diagnostic imaging and radiotherapy. It specifically binds to PSMA on prostate cancer cells and enters cells through clathrin-dependent endocytosis, resulting in higher tumor retention and reduced renal uptake. PDI2 is applicable in research involving prostate cancer and castration-resistant metastatic prostate cancer.
    Formel:C59H90N12O19
    Molekulargewicht:1271.41

    Ref: TM-TP4364